Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).

Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).

Neuroblastomas (NBs) were assessed according to INSS recommendations including MIBG scan and extensive bone marrow staging to eliminate metastatic spread. Patients with unresectable tumour received primary chemotherapy including two courses of carboplatin-etoposide (CE) and two of vincristine-cyclop...

Full description

Bibliographic Details
Main Authors: Rubie, H., Michon, J., Plantaz, D., Peyroulet, M. C., Coze, C., Frappaz, D., Chastagner, P., Baranzelli, M. C., Méchinaud, F., Boutard, P., Lutz, P., Perel, Y., Leverger, G., de Lumley, L., Millot, F., Stéphan, J. L., Margueritte, G., Hartmann, O.
Format: Online
Language:English
Published: Nature Publishing Group 1998
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150389/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150389/

Similar Items